These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 2387533

  • 21. Monoclonal antibody assays for measuring ovarian tumor antigen in blood. Detection of NB/70K in patients with ovarian cancer and nongynecologic diseases.
    Knauf S.
    Cancer; 1988 Sep 01; 62(5):922-5. PubMed ID: 3409174
    [Abstract] [Full Text] [Related]

  • 22. The importance of polyamine determination in monitoring malignant gynaecological tumours.
    Szarka G, Pulay T, Csömör S, Tran-Phuong-Mai, Schumann B.
    Acta Chir Hung; 1988 Sep 01; 29(4):365-72. PubMed ID: 3239336
    [Abstract] [Full Text] [Related]

  • 23. Effective head and neck tumor markers. The continuing quest.
    Ropka ME, Goodwin WJ, Levine PA, Sasaki CT, Kirchner JC, Cantrell RW.
    Arch Otolaryngol Head Neck Surg; 1991 Sep 01; 117(9):1011-4. PubMed ID: 1910716
    [Abstract] [Full Text] [Related]

  • 24. Plasma lipid-bound sialic acid alterations in neoplastic diseases.
    Dwivedi C, Dixit M, Hardy RE.
    Experientia; 1990 Jan 15; 46(1):91-4. PubMed ID: 2298288
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Significance of lipid-associated sialic acid and CA 19-9 as tumor markers for renal cell carcinoma.
    Echenique JE, Graham SD.
    Urology; 1988 Nov 15; 32(5):397-400. PubMed ID: 3188302
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma: a critical appraisal.
    van Haaften-Day C, Shen Y, Xu F, Yu Y, Berchuck A, Havrilesky LJ, de Bruijn HW, van der Zee AG, Bast RC, Hacker NF.
    Cancer; 2001 Dec 01; 92(11):2837-44. PubMed ID: 11753957
    [Abstract] [Full Text] [Related]

  • 33. Tumor marker trends in asymptomatic women at risk for ovarian cancer: relevance for ovarian cancer screening.
    Cane P, Azen C, Lopez E, Platt LD, Karlan BY.
    Gynecol Oncol; 1995 May 01; 57(2):240-5. PubMed ID: 7729742
    [Abstract] [Full Text] [Related]

  • 34. [Ovarian cancer--a comparison between CT diagnosis and serum tumor markers].
    Wakabayashi Y, Yachida M, Akata S, Kawana K, Kotake F, Kakizaki D, Abe K, Negishi N, Akiya K.
    Gan No Rinsho; 1988 Jan 01; 34(1):52-6. PubMed ID: 3422324
    [Abstract] [Full Text] [Related]

  • 35. [Comparative study of serum lipid-bound sialic acid and carcinoembryonic antigen in patients with lung cancer].
    Zhu X.
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Feb 01; 13(1):25-7, 61. PubMed ID: 2165867
    [Abstract] [Full Text] [Related]

  • 36. Five tumor markers in lung cancer: significance of total and "lipid"-bound sialic acid.
    Kakari S, Stringou E, Toumbis M, Ferderigos AS, Poulaki E, Chondros K, Dema A, Kotsovoulou V, Pavlidis N.
    Anticancer Res; 1991 Feb 01; 11(6):2107-10. PubMed ID: 1663720
    [Abstract] [Full Text] [Related]

  • 37. Serum sialic acid as a marker of pancreatic cancers.
    Gruszewska E, Chrostek L, Cylwik B, Tobolczyk J, Szmitkowski M, Kuklinski A, Kedra B.
    Clin Lab; 2013 Feb 01; 59(7-8):781-8. PubMed ID: 24133906
    [Abstract] [Full Text] [Related]

  • 38. Tumor markers in epithelial ovarian cancer. Clinical applications.
    Hempling RE.
    Obstet Gynecol Clin North Am; 1994 Mar 01; 21(1):41-61. PubMed ID: 8015766
    [Abstract] [Full Text] [Related]

  • 39. [New prospects in the combined use of tumor markers in epithelial neoplasms of the ovary].
    Indraccolo SR, Cecchi A, Thodos A, Brandi S, Carta G.
    Ann Ostet Ginecol Med Perinat; 1991 Mar 01; 112(1):36-40. PubMed ID: 1929097
    [Abstract] [Full Text] [Related]

  • 40. Predictive value of multiple tumor marker assays in second-look procedures for ovarian cancer.
    Benedetti Panici P, Scambia G, Baiocchi G, Iacobelli S, Mancuso S.
    Gynecol Oncol; 1989 Dec 01; 35(3):286-9. PubMed ID: 2599461
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.